The radial artery access sheath is used to gain arterial access and facilitate the insertion of catheters or other equipment for diagnostic and vascular interventions.[1] Compared with procedures performed via the commonly used femoral artery access route, procedures performed via the radial artery route allow shorter recovery time, earlier ambulation, earlier discharge, and lower incidences of access-site complications, as well as being advantageous for patients with occlusive aortoiliac disease or peripheral vascular disease.
However, specific challenges exist in using radial artery sheath access. The radial artery is smaller than the femoral artery, and thus, more finesse and experience are required to access this vessel. In addition, a smaller sheath precludes the use of larger catheters and equipment, which may be needed for major operations. Finally, radial artery spasm is a risk, necessitating routine use of antispasmodic medications.
Indications for radial artery sheath insertion include the following:
Absolute contraindications for radial artery sheath insertion include the following:
Relative contraindications for radial artery sheath insertion include the following:
Before attempting to insert a radial artery sheath, the operator should be familiar with the anatomy of the blood supply to the hand. The radial artery is a branch of the brachial artery, originating above the elbow. It passes down the forearm between the tendons of the brachioradialis and the flexor carpi radialis and winds around the lateral aspect of the radius. It then crosses the floor of the anatomic snuffbox to pass between the two heads of the first dorsal interosseous muscle to join the deep palmar arch.
The collateral circulation is supplied via the ulnar artery and should be assessed by performing the Allen test. This can be done either visually or with oximetry. An abnormal Allen test result is a contraindication for radial access.
Two types of needles are commonly used for arterial puncture, as follows:
The choice of the needle set is dictated by the operator’s preference and familiarity.[7] Depending on the procedure, different diagnostic and guiding catheters can subsequently be inserted through the sheath. Various kits that include both the needle and the radial sheath are available (see the image below).
The equipment list for radial artery sheath insertion includes the following:
A combination of local anesthesia and light sedation is often effective before the procedure. A popular choice of local anesthetic is 1-2 mL of 1% lidocaine. Topical anesthetic cream can be applied to alleviate discomfort and reduce the amount of local anesthetic injected. Midazolam 1-5 mg for sedation is helpful to reduce vascular tone and the frequency of arterial spasm.
All obstructing jewelry and clothing should be removed from the wrist that is being accessed. Intravenous access should always be obtained, preferably on the contralateral side; alternatively, central venous access may be obtained if necessary. The wrist should be shaved to remove excess hair if necessary. A medical towel can be placed underneath the wrist to keep it in hyperextension (see the image below), or a hyperextension splint can be applied.
The skin is sterilized with an alcohol-based skin preparation. The groin should also be prepared for access in the event of a failed radial artery insertion. The angiography drape is applied so as to expose the wrist in an area where the radial artery pulse will be palpable.
Most radial artery sheaths have a hydrophilic coating to minimize vasospasm.[8] Agents such as diltiazem, verapamil, nitroglycerin, papaverine, or adenosine may be given in addition to prevent radial artery spasm; they may be administered during sheath advancement through the guide wire, after completion of the procedure but before removal of the radial sheath, or both.
Heparin is routinely given to prevent thrombosis at the site of sheath insertion. The amount used ranges from 40 to 70 U/kg, depending on the duration and degree of vascular intervention required. Heparin may be administered either via the arterial sheath or intravenously (IV). When given intra-arterially, it is often diluted with the patient’s own blood, which can be extracted from the sidearm.
After the wrist has been appropriately prepared, palpate for the radial artery (see the image below). Infiltrate local anesthetic subcutaneously at least 2 cm proximal to the radial styloid process (in the region where the radial artery pulse is best appreciated) to form a small wheal.
Insert the cannula-over-needle through the skin at an angle of approximately 45°, directing it proximally toward the radial artery at its expected course. Advance the device slowly until pulsatile bright (arterial) backflow of blood is achieved and is visible in the needle (see the image below). Gently feed the cannula through, and remove the needle. Backflow of blood through the cannula should still exist.
Unsuccessful radial artery puncture commonly provokes radial artery spasm, temporary loss of the radial pulse at the site of puncture, and hematoma formation. In this situation, the following measures may be attempted:
After the artery has been successfully punctured, introduce the guide wire through the cannula. Once the guide wire has been smoothly advanced through the device, remove the cannula while leaving the guide wire in place (see the image below); the guide wire will be used to guide the sheath into the radial artery. To avoid accidental embolization of the guide wire, the length of wire left exposed outside the patient must always be greater than the length of the sheath. Always hold onto the wire with a hand.
Difficulty in advancing the guide wire may be caused by the artery being in spasm, the wire entering a small branch vessel, or the needle partly entering or having gone through the vessel wall. In this situation, the following measures may be attempted:
Introduce the sheath (with the dilator inserted) over the guide wire into the radial artery. A small superficial skin incision may be made where the guide wire enters through the skin to facilitate smooth passage of the sheath. If resistance occurs, the tip of the wire may be watched via fluoroscopy. If resistance is met and the sheath is definitely in the artery, the guide wire may be removed, and verapamil 2.5-5 mg, nitroglycerin 200 µg, or both may be injected through the sheath dilator.
After the insertion of the sheath, if passing a 0.035-in. guide wire is difficult, angiography may be performed to check the arterial anatomy.
Once the sheath is fully advanced, the guide wire and the dilator assembly may be removed (see the image below). After the removal of the dilator, the sidearm may be used for administration of compatible medications (eg, heparin, verapamil, and nitroglycerin; diazepam must not be administered intra-arterially).
Inject antispasmodic agents (eg, verapamil 2.5-5 mg[9] diluted in blood) through the sheath via the sidearm. Anticoagulants (eg, heparin 5000 U) may be administered either via the sheath or IV, depending on the procedure performed. If necessary, the sheath may be secured with a transparent bandage.
In some cases, the sheath proves difficult to remove, usually as a consequence of vasospasm. In this situation, the following measures may be attempted:
In general, sheath insertion with the micropuncture needle is similar to sheath insertion with the cannula-over-needle. However, the needle must be held steady once backflow occurs. Advance the guide wire through the needle in the same fashion as for the cannula-over-needle technique, again taking care not to lose the guide wire. If the wire advances smoothly, remove the needle while keeping the wire in place, then proceed with the introduction of the sheath as described above.
Complications of radial artery sheath insertion include the following[10] :
Rashid et al, in a review of RAO after transradial interventions, reported postintervention RAO rates ranging from less than 1% to 33%.[16] In this review, a higher heparin dose was the most efficacious means of reducing RAO; shorter compression times were also found to reduce RAO. Distal puncture sites (0-1 cm from the styloid process) may be associated with higher RAO rates after transradial interventions.[17]
In a study of cases of RAO arising after radial artery access in patients requiring repeat cardiac catheterization, Schulte-Hermes et al found that it was feasible to gain access to an occluded radial artery by means of percutaneous transluminal angioplasty.[18]
Distal transradial access (DTRA) has been advocated as having several potential advantages over conventional transradial access (TRA), including greater operator and patient comfort, faster hemostasis, and lower risk of proximal RAO. In a study by Oliveira et al (N = 3683), the use of DTRA as standard for routine coronary interventions was found to be safe and feasible.[19]
The DISCO RADIAL (Distal vs Conventional Radial Access) trial (N = 1307) compared conventional TRA (n = 657) with DTRA (n = 650) for coronary angiography and intervention; the primary endpoint was the incidence of forearm RAO assessed by vascular ultrasonography at discharge.[20] The two approaches had equally low RAO rates. DTRA was associated with a higher crossover rate but a shorter hemostasis time. In the authors' view, conventional TRA remains the gold-standard vascular access in this setting, but DRA is a valid alternative.
The goals of pharmacotherapy are to reduce morbidity and prevent complications.
Anticoagulants prevent recurrent or ongoing thromboembolic occlusion of the vertebrobasilar circulation. In patients with heparin-induced thrombocytopenia, LVAD implantation has been performed successfully, albeit with additional risk, by using alternative anticoagulants.
Heparin may be used if thrombocytopenia is not present. Heparin augments the activity of antithrombin III and prevents the conversion of fibrinogen to fibrin. It does not actively lyse but is able to inhibit further thrombogenesis. Heparin prevents the recurrence of a clot after spontaneous fibrinolysis.
Heparin is routinely given to prevent thrombosis at the site of sheath insertion. The amount used ranges from 40-70 U/kg, depending on the duration and degree of vascular intervention required. Heparin may be administered either via the arterial sheath or intravenously (IV). When given intra-arterially, it is often diluted with the patient's own blood, which can be extracted from the sidearm.
Vasodilators dilate the mesenteric arterial system. Thereby, they reverse reactive arterial vasospasms. They may be administered during sheath advancement through the guide wire, after completion of the procedure but before removal of the radial sheath, or both.
Papaverine is a benzylisoquinoline derivative that exerts a direct nonspecific relaxant effect on vascular, cardiac, and other smooth muscle. In the absence of peritoneal signs, it is the drug of choice for acute myocardial infarction (AMI) of arterial origin if angiography indicates good distal perfusion. Papaverine is advocated for the treatment of the widespread vasoconstriction that follows therapy for superior mesenteric artery (SMA) emboli by other modalities.
Nitroglycerin produces vasodilator effects on the peripheral veins and arteries.
Agents that prevent radial artery spasm may be used.
When used in myocardial perfusion, scintigraphy reveals areas of insufficient blood flow. Adenosine increases blood flow and causes coronary vasodilation in normal coronary arteries, while it causes little or no increase in stenotic coronary arteries. Adenosine is also a short-acting agent that alters potassium conductance into cells and results in hyperpolarization of nodal cells.
Calcium channel blockers are used to prevent radial artery spasm.
During depolarization, diltiazem inhibits calcium ions from entering slow channels and voltage-sensitive areas of vascular smooth muscle and myocardium.
Verapamil relaxes coronary vascular smooth muscle and produces coronary vasodilation.